The Characteristics of Treated Pulmonary Arterial Hypertension Patients in Ontario

Author:

Vaid Haris M.1,Camacho Ximena2,Granton John T.345,Mamdani Muhammad M.25678,Yao Zhan2,Singh Samantha2,Juurlink David N.257910,Gomes Tara27811

Affiliation:

1. School of Medicine, Queen’s University, 15 Arch Street, Kingston, ON, Canada K7L 3N6

2. The Institute for Clinical Evaluative Sciences, 2075 Bayview Avenue G1 06, Toronto, ON, Canada M4N 3M5

3. Toronto General Hospital, 200 Elizabeth Street, Toronto, ON, Canada M5G 2C4

4. University Health Network, 399 Bathurst Street, Toronto, ON, Canada M5T 2S8

5. Department of Medicine, The University of Toronto, 1 King’s College Circle No. 3172, Toronto, ON, Canada M5S 1A8

6. The Department of Medicine, St. Michael’s Hospital, 30 Bond Street, Toronto, ON, Canada M5B 1W8

7. Department of Health Policy, Management, and Evaluation, The University of Toronto, 155 College Street, Toronto, ON, Canada M5T 3M6

8. The Leslie Dan Faculty of Pharmacy, The University of Toronto, 144 College Street, Toronto, ON, Canada M5S 3M2

9. The Sunnybrook Research Institute, 2075 Bayview Avenue, Toronto, ON, Canada M4N 3M5

10. Department of Pediatrics, The University of Toronto, 555 University Avenue Black Wing, 1436 Toronto, ON, Canada M5G 1X8

11. Keenan Research Centre, The Li Ka Shing Knowledge Institute, St. Michael’s Hospital, 209 Victoria Street, Toronto, ON, Canada M5B 1T8

Abstract

Background. There are no Canadian prevalence studies on pulmonary arterial hypertension (PAH) to date. We described the characteristics of treated PAH patients and the healthcare utilization and costs associated with PAH in a population of public drug plan beneficiaries in Ontario, Canada.Methods. A retrospective cross-sectional analysis was conducted between April 2010 and March 2011 to identify treated PAH patients using population-based health administrative databases. We investigated demographic and clinical characteristics of treated PAH patients and conducted a cohort study to determine treatment patterns, healthcare utilization, and associated costs, over a one-year follow-up period (March 2012).Results. We identified 326 treated PAH cases in Ontario’s publicly funded drug plan. Overall mean age was 59.4 years (±20.3 years) and over 77% of cases were women (n=251). Combination therapy was used to treat 22.9% (n=69) of cases, costing an average of $4,569 (SD $1,544) per month. Median monthly healthcare costs were $264 (IQR $96–$747) for those who survived and $2,021 (IQR $993–$6,399) for those who died over a one-year period, respectively (p<0.01).Conclusions. PAH care in Ontario is complex and has high healthcare costs. This data may help guide towards improved patient management.

Funder

Ontario Ministry of Health and Long-Term Care

Publisher

Hindawi Limited

Subject

Pulmonary and Respiratory Medicine

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3